Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on April 14, 2025
Nominate a Nurse in Your Life: Honoring our March Nurse Giveaway Winners
EIN Presswire
·
April 14, 2025
Celebrating nurses who go above and beyond—Snellings Law honors three local healthcare heroes through its North Texas Nurse Giveaway. FRISCO, TX, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Snellings Law is proud to spotlight three extraordinary …
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
GlobeNewswire
·
April 14, 2025
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of …
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
GlobeNewswire
·
April 14, 2025
LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their CEO, …
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
GlobeNewswire
·
April 14, 2025
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: …
BioSyent to Attend Planet MicroCap Showcase
GlobeNewswire
·
April 14, 2025
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April …
Cue Biopharma Announces Proposed Public Offering
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Cue Biopharma to Host Business Update Call and Webcast
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Aurora Spine Announces the Resignation of Board Director James Snow
GlobeNewswire
·
April 14, 2025
CARLSBAD, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 14, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell …
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 14, 2025
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …
TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2024 Financial Results
GlobeNewswire
·
April 14, 2025
FREDERICK, Md., April 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
April 14, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, April 14, 2025 (GLOBE NEWSWIRE) -- Market: Euronext Paris / Nasdaq …
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
GlobeNewswire
·
April 14, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 14 avr. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext Compartiment : B Code ISIN : …
BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and Preliminary Full-Year 2024 Revenue of $301.8 Million
GlobeNewswire
·
April 14, 2025
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or $0.94 per share, marking the fourth consecutive quarter …
SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025
GlobeNewswire
·
April 14, 2025
SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on …
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
GlobeNewswire
·
April 14, 2025
MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …
Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stock
GlobeNewswire
·
April 14, 2025
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at-the …
NeuroPace Provides Update on Tariff Status
GlobeNewswire
·
April 14, 2025
-- Minimal expected impact to operations and financial results -- -- Company to report first quarter 2025 financial results on May 13, 2025 -- MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device …
Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
April 14, 2025
KIRKLAND, Wash., April 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, today reported financial results for the third quarter fiscal 2025, which ended …
Sage Medical Campus Breaks Ground in El Paso’s Cimarron Community
EIN Presswire
·
April 14, 2025
Sage at Cimarron, a 88,500-sq-ft medical campus at 7255 Paseo Del Norte, brings spa-like healthcare to El Paso’s growing Cimarron community EL PASO, TX, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Today, El Paso celebrated the groundbreaking of …